Open access
Oct 2026
Plasma Angiotensin-Converting Enzyme as a Prioritized Candidate Target for Alzheimer's Disease: Evidence From Proteome-Wide Mendelian Randomization and a Large Prospective Cohort Study.
Genetic analyses prioritized angiotensin-converting enzyme as a candidate target, and a conventional observational analysis in a large prospective cohort provided supportive evidence that regular angiotensin-converting enzyme inhibitor use was associated with a higher AD risk.
Pei-Guan Huang, Hai-Bo Tang, Ze-Ying Feng et al.
· Journal of the American Hear... · 0 citations